Saturday, October 31, 2026

Back to today

When the liquidity does not add up

Arbor Realty Trust’s dividend suspension is presented as creating $60 million of liquidity, raising questions about its ability to meet 2027 debt maturities.

From X

@StableBread

Fajasy on X

85.5% of the BWX Technologies $BWXT stock insiders have sold in the open market since January 2025 came from CEO Rex Geveden. All 14 open-market transactions since then were sales, totaling 129,322 shares and $20.1M. Geveden accounts for 110,625 of the shares and $17.2M, in two phases: 1) Discretionary sales: 45,625 shares at $107.40 on February 26, 2025, and 25,000 at $179.00 on August 6, 2025, both two days after an earnings release and neither under a 10b5-1 plan (a pre-set trading plan). 2) Plan sales: On August 11, 2025, five days after the second sale, he adopted a 10b5-1 plan to sell up to 40,000 shares through August 14, 2026. He sold 10,000 shares/quarter under the plan, at $197.90, $203.26, $204.81, and $172.50, using up all 40,000. He still holds 192,491 shares directly ($28.0M at $145.70). The last two 10-Qs show no new plans adopted in H1 2026, and the Q3 10-Q, due with results on November 2, will show whether he adopted another plan after the first expired. The other eight sales, by seven executives and directors, totaled 18,697 shares and $2.9M. Most of this selling carries little signal. The other insiders’ $2.9M is small, and Geveden’s 40,000 plan shares were scheduled in August 2025. His two discretionary sales matter more. They totaled 70,625 shares ($9.4M) outside any plan, and including the plan sales, he’s sold about a third of his shares since February 2025. But both came right after $BWXT reported earnings, not ahead of them, at $107.40 and $179.00, well below the $238.42 peak. So the selling isn’t a warning sign, but with no insider buying during the drop, insiders aren’t signaling a bottom.
@StableBread

Fajasy on X

Excluding medical isotopes, commercial power revenue at BWX Technologies $BWXT nearly tripled, from ~$400M in 2023 to ~$1.1B expected in 2026. $BWXT’s commercial segment is growing much faster than its government segment, driven by (1) Ontario rebuilding its reactors, (2) Canada’s plan for new ones, and (3) the U.S. push for new AP1000 reactors. Its commercial backlog more than doubled to $1.6B. Kinectrics, a Toronto-based nuclear engineering and testing firm acquired in May 2025, explains part of the jump. Commercial revenue grew 72% in Q2 2026, or 33% excluding the acquisition. In Ontario, utilities are rebuilding reactors to run for decades longer. $BWXT is building 48 steam generators for Ontario Power Generation’s (OPG) Pickering refurbishment, part of more than CAD$1B (~$700M) of contracts. The same contracts cover the reactor pressure vessel for the first BWRX-300 at OPG’s Darlington station, a 300 MWe small modular reactor (SMR) designed by GE Vernova Hitachi. The 10-K calls $BWXT “the only commercial heavy nuclear component manufacturer in North America.” Notably, its Cambridge, Ontario plant is turning out more than 1.5 steam generators/month vs. the 1/month its schedule requires, per $BWXT’s Investor Day on September 29, 2026. Beyond refurbishments, Canada’s June 2026 nuclear strategy calls for “up to ten new large-scale reactors,” with two under construction by 2035 and five more planned or under development by 2040. $BWXT already has licensing and early engineering contracts for the large reactors planned by OPG and Bruce Power, the private operator of Ontario’s Bruce nuclear station. John MacQuarrie, president of Commercial Operations, estimated Canada’s new-build market at CAD$120-150B (~$84-105B) at Investor Day. Slide 31 shows $BWXT’s potential revenue per new reactor: → CANDU (Canada’s heavy-water reactor design): $350-700M per reactor. → AP1000 (Westinghouse’s large U.S. design): Low hundreds of millions of dollars. → SMRs: $50-100M.

CVX Earnings Review

Chevron’s Q3 revenue rose 35% to $65.2 billion and EBITDA 75% to $20.2 billion, while production trailed guidance and refining margins…

SNY Earnings Review

Sanofi raised FY26 guidance after Q3 sales grew 14.3% at constant currency, led by 34.8% Dupixent growth; vaccines declined 6.6%.

PSN · long

Parsons CORP

Parsons generates roughly half of its $6.4 billion revenue from Federal Solutions, serving defense and intelligence customers.

Another Haircut with Avy the Barber

SoFi’s stock case hinges on interest rates, tangible book value and private-credit loan sales after its $1.5 billion equity offering.

Intel Q3 2026: Dead Inside

Intel’s Q3 2026 datacenter CPU shortage reflects wafer-start planning failures, not substrate constraints, after demand shifted from client…

INTC Q3 FY12/26 Earnings Review

Intel's Q3 revenue rose 21% to $16.5 billion, led by 78% data-center and AI growth, but Q4 guidance of $15.5 billion trailed consensus.

Twilio CEO: ‘Buy the dip!’

Twilio CEO Khozema Shipchandler urged investors to “buy the dip” after earnings sent the software maker’s shares down 17% after hours.

Publications we follow

Every publication on this site, hand-picked.

129 publications

Newsletters 109

X accounts we follow

Every account on this site, hand-picked.

91 accounts

Investor letters we follow

190 firms

Sectors

Ordered by how often our editor reaches for them.